Follow along on our year-long guide to Ulcerative Colitis, exploring the latest recommendations and research on diagnosis, treatment, and prevention of this chronic, inflammatory bowel disease. Each month will delve into another aspect, including warning signs, symptoms, and risks; management of diarrhea, pain, bleeding, weight loss, fatigue, fever, and long-term complications; medications and surgery; special concerns about the disease in children; types, and distinguishing ulcerative colitis from irritable bowel syndrome, Crohn's disease, and other GI ailments; emotional, psychosocial, and reproductive/sexual health concerns; comorbidities; self-care related to diet, exercise, behavioral interventions, and overall well-being to live with the disease; promising treatments in the pipeline; unique case studies -- all of which has undergone expert review. Every installment will include a downloadable, printable information resource for patients.
–Ulcerative colitis is one of the most common chronic autoimmune conditions in Western countries
For Your Patients: What Is Ulcerative Colitis?
–What to look for and how to look
–A closer look at pathogenesis and risk factors
For Your Patients: UC--Why Me?
–Immunosuppression was instigator in rare opportunistic infection in this setting
–Here's what the guidelines say
For Your Patients: Starting Drug Therapy for Ulcerative Colitis
–Managing ulcerative colitis involves more than drugs
For Your Patients: Diet and Lifestyle Considerations
–Next steps when patients do not obtain remission or lose it after initial therapy
–Rare aggressive tumor in patient with long-standing ulcerative colitis
–Managing patients' physical symptoms is only part of the story
For Your Patients: Living With Ulcerative Colitis
–An alternative when drugs and behavioral approaches fail
For Your Patients: Would Surgery Help My Ulcerative Colitis?
–Colorectal cancer extra-intestinal complications to consider
–A look at new treatments in development
For Your Patients: Future Treatments for Ulcerative Colitis